Endoscopic ultrasound staging of cholangiocarcinoma

Current Opinion in Gastroenterology

Volumn 28, Issue 3, 2012, Pages 244-252

  Levy, Michael J ^a   Heimbach, Julie K ^a   Gores, Gregory J ^a  

^a MAYO CLINIC   (United States)

Author keywords

biliary tract malignancy; cholangiocarcinoma; diagnosis; endoscopic ultrasound; fine needle aspiration

Indexed keywords

ASPIRATION BIOPSY; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; ENDOSCOPIC ECHOGRAPHY; HUMAN; LYMPH NODE; REVIEW; TUMOR SEEDING;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOPSY, FINE-NEEDLE; CHOLANGIOCARCINOMA; EARLY DETECTION OF CANCER; ENDOSONOGRAPHY; FEMALE; HUMANS; IATROGENIC DISEASE; MALE; NEOPLASM SEEDING; NEOPLASM STAGING; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84859890370     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32835005bc     Document Type: Review

References (62)

1. Maggs JR, Chapman RW. An update on primary sclerosing cholangitis. Curr Opin Gastroenterol 2008; 24:377-383. (Pubitemid 351535898)
2. Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996; 224:628-638. (Pubitemid 26384886)
3. Kosuge T, Yamamoto J, Shimada K, et al. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999; 230:663-671. (Pubitemid 30191828)
4. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234:507-517; discussion 517-519.
5. DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007; 245:755-762. (Pubitemid 46684105)
6. Heimbach JK, Gores GJ, Haddock MG, et al. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 2004; 24:201-207. (Pubitemid 38738348)
7. Heimbach JK, Gores GJ, Haddock MG, et al. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 2006; 82:1703-1707. (Pubitemid 46035655)
8. Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005; 242:451-458; discussion 458-461.
9. Fritscher-Ravens A, Broering DC, Knoefel WT, et al. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am J Gastroenterol 2003; 99:45-51. (Pubitemid 38679100)
10. Byrne MF, Gerke H, Mitchell RM, et al. Yield of endoscopic ultrasound-guided fine-needle aspiration of bile duct lesions. Endoscopy 2004; 36:715-719. (Pubitemid 39149415)
11. Lee JH, Salem R, Aslanian H, et al. Endoscopic ultrasound and fine-needle aspiration of unexplained bile duct strictures. Am J Gastroenterol 2004; 99:1069-1073. (Pubitemid 38917810)
12. Eloubeidi MA, Chen VK, Jhala NC, et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin Gastroenterol Hepatol 2004; 2:209-213. (Pubitemid 38293307)
13. Rosch T, Hofrichter K, Frimberger E, et al. ERCP or EUS for tissue diagnosis of biliary strictures? A prospective comparative study. Gastrointest Endosc 2004; 60:390-396. (Pubitemid 39164248)
14. Mohamadnejad M, DeWitt JM, Sherman S, et al. Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experience. Gastrointest Endosc 2011; 73:71-78.
15. Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2011; 8:512-522.
16. Ponchon T, Gagnon P, Berger F, et al. Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study. Gastrointest Endosc 1995; 42:565-572.
17. Khan SA, Davidson BR, Goldin R, et al., British Society of G. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002; 51 (Suppl 6):VI1-VI9. (Pubitemid 35216840)
18. Gores GJ, Nagorney DM, Rosen CB. Cholangiocarcinoma: is transplantation an option? For whom? J Hepatol 2007 47 455-459. (Pubitemid 47331754)
19. Moreno Luna LE, Kipp B, Halling KC, et al. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. Gastroenterology 2006; 131:1064-1072. (Pubitemid 44498705)
20. Levy MJ, Baron TH, Clayton AC, et al. Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures. Am J Gastroenterol 2008; 103:1263-1273. (Pubitemid 351677975)
21. Fritcher EGB, Kipp BR, Halling KC, et al. A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures. Gastroenterology 2009; 136:2180-2186.
22. Paquin SC, Gariepy G, Lepanto L, et al. A first report of tumor seeding because of EUS-guided FNA of a pancreatic adenocarcinoma. Gastrointest Endosc 2005; 61:610-611. (Pubitemid 40462209)
23. Shah JN, Fraker D, Guerry D, et al. Melanoma seeding of an EUS-guided fine needle track. Gastrointest Endosc 2004; 59:923-924. (Pubitemid 38879330)
24. Doi S, Yasuda I, Iwashita T, et al. Needle tract implantation on the esophageal wall after EUS-guided FNA of metastatic mediastinal lymphadenopathy. Gastrointest Endosc 2008; 67:988-990.
25. Ito Y, Asahi S, Matsuzuka F, et al. Needle tract implantation of follicular neoplasm after fine-needle aspiration biopsy: report of a case. Thyroid 2006; 16:1059-1062. (Pubitemid 46141310)
26. Suzuki K, Takamochi K, Funai K, Kazui T. Needle tract implantation clearly visualized by computed tomography following needle biopsy of malignant mesothelioma. Eur J Cardiothorac Surg 2006; 29:1051. (Pubitemid 43728616)
27. Fowler N, Asatiani E, Cheson B. Needle tract seeding after bone marrow biopsy in non-Hodgkin lymphoma. Leuk Lymph 2008; 49:156-158. (Pubitemid 351146897)
28. Chang S, Kim SH, Lim HK, et al. Needle tract implantation after percutaneous interventional procedures in hepatocellular carcinomas: lessons learned from a 10-year experience. Korean J Radiol 2008; 9:268-274.
29. Rowe LR, Mulvihill SJ, Emerson L, Gopez EV. Subcutaneous tumor seeding following needle core biopsy of hepatocellular carcinoma. Diagn Cytopathol 2007; 35:717-721. (Pubitemid 350035045)
30. Liu Y-W, Chen C-L, Chen Y-S, et al. Needle tract implantation of hepatocellular carcinoma after fine needle biopsy. Dig Dis Sci 2007; 52:228-231. (Pubitemid 46122072)
31. Sakata J, Shirai Y, Wakai T, et al. Catheter tract implantation metastases associated with percutaneous biliary drainage for extrahepatic cholangiocarcinoma. World J Gastroenterol 2005; 11:7024-7027. (Pubitemid 43126064)
32. Gerhards MF, Gonzalez DG, ten Hoopen-Neumann H, et al. Prevention of implantation metastases after resection of proximal bile duct tumours with preoperative low dose radiation therapy. Eur J Surg Oncol 2000; 26:480-485.
33. Lundstedt C, Stridbeck H, Andersson R, et al. Tumor seeding occurring after fine-needle biopsy of abdominal malignancies. Acta Radiol 1991; 32:518-520.
34. Smith EH. Complications of percutaneous abdominal fine-needle biopsy. Radiology 1991; 178:253-258.
35. Castells A, Boix L, Bessa X, et al. Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction. Br J Cancer 1998; 78:1368-1372. (Pubitemid 28495252)
36. Wyld DK, Selby P, Perren TJ, et al. Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer 1998; 79:288-293. (Pubitemid 28262216)
37. Gunn J, McCall JL, Yun K, Wright PA. Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction. Lab Invest 1996; 75:611-616. (Pubitemid 26346810)
38. Soeth E, Roder C, Juhl H, et al. The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20- specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int J Cancer 1996; 69:278-282. (Pubitemid 26298291)
39. Nakamura T, Yasumura T, Hayashi K, et al. Immunocytochemical detection of circulating esophageal carcinoma cells by immunomagnetic separation. Anticancer Res 2000; 20:4739-4744. (Pubitemid 32127720)
40. Mori M, Mimori K, Ueo H, et al. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcriptionpolymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 1998; 16:128-132. (Pubitemid 28041589)
41. Miyazono F, Natsugoe S, Takao S, et al. Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery. Ann Surg 2001; 233:189-194. (Pubitemid 32106072)
42. Z'Graggen K, Centeno BA, Fernandez-del Castillo C, et al. Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients. Surgery 2001; 129:537-546. (Pubitemid 32374984)
43. Hardingham JE, Kotasek D, Sage RE, et al. Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease. Mol Med 1995; 1:789-794. (Pubitemid 3013087)
44. Funaki NO, Tanaka J, Imamura M. Quantitative analysis of alpha-fetoprotein mRNA in circulating peripheral blood of patients with hepatocellular and alpha-fetoprotein-producing gastric carcinomas. Life Sci 1998; 62:1973-1984. (Pubitemid 28234306)
45. Uchikura K, Takao S, Nakajo A, et al. Intraoperative molecular detection of circulating tumor cells by reverse transcription-polymerase chain reaction in patients with biliary-pancreatic cancer is associated with hematogenous metastasis. Ann Surg Oncol 2002; 9:364-370. (Pubitemid 34496724)
46. Koike M, Hibi K, Kasai Y, et al. Molecular detection of circulating esophageal squamous cell cancer cells in the peripheral blood. Clin Cancer Res 2002; 8:2879-2882. (Pubitemid 35025734)
47. Piva MG, Navaglia F, Basso D, et al. CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging. Oncology 2000; 59:323-328.
48. Yeh KH, Chen YC, Yeh SH, et al. Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19): possible clinical significance in advanced gastric cancer. Anticancer Res 1998; 18:1283-1286.
49. Bessa X, Elizalde JI, Boix L, et al. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology 2001; 120:1084-1092. (Pubitemid 32246662)
50. Levy MJ, Gleeson FC, Campion MB, et al. Prospective cytological assessment of gastrointestinal luminal fluid acquired during EUS: a potential source of false-positive FNA and needle tract seeding. Am J Gastroenterol 2010; 105:1311-1318.
51. Micames C, Jowell PS, White R, et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc 2003; 58:690-695. (Pubitemid 37370481)
52. Silva MA, Hegab B, Hyde C, et al. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut 2008; 57:1592-1596.
53. Heimbach JK, Sanchez W, Rosen CB, Gores GJ. Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. HPB 2011; 13:356-360.
54. Wetter LA, Ring EJ, Pellegrini CA, Way LW. Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors). Am J Surg 1991; 161:57-62; discussion 62-63.
55. Verbeek PC, van Leeuwen DJ, de Wit LT, et al. Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors. Surgery 1992; 112:866-871.
56. Vauthey JN, Blumgart LH. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 1994; 14:109-114. (Pubitemid 24153079)
57. Gerhards MF, Vos P, van Gulik TM, et al. Incidence of benign lesions in patients resected for suspicious hilar obstruction. Br J Surg 2001; 88:48-51. (Pubitemid 32066056)
58. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215:31-38.
59. Nathan H, Aloia TA, Vauthey J-N, et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2009; 16:14-22.
60. Gleeson FC, Rajan E, Levy MJ, et al. EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc 2008; 67:438-443. (Pubitemid 351260042)
61. Puhalla H, Gruenberger T, Pokorny H, et al. Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosis. World J Surg 2003; 27:680-684. (Pubitemid 36961099)
62. Nakagawa T, Kamiyama T, Kurauchi N, et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 2005; 29:728-733. (Pubitemid 41187533)